In this pilot study we analyzed the frequency and phenotype of CEC, CEP and selected CD11b+ cell subsets in breast cancer patients diagnosed with metastasis before and during the first cycle of therapy with paclitaxel ± bevacizumab. Here, ITGAM is linked to breast cancer.